KV

Kavuru Vimal Kumar

Active Director Director DIN 00502935
DIN 00502935 First appointment Oct 2007 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 13 historical roles
Total affiliations 22 Since Oct 2007
Shareholding value •••• Premium profile

About Kavuru Vimal Kumar

Data last updated:

Kavuru Vimal Kumar is a Director at Cronus Pharma Specialities India Private Limited (since 2018), Director at Anshra Realty Private Limited (since 2023) and Director at Nortic Realty Private Limited (since 2023), and holds 6 more current directorships. The companies operate in Chemicals, Real Estate and Construction and Printing & Publishing. The 6 current companies with reported revenue have a combined latest revenue of ₹496 Cr; the largest is Cronus Pharma Specialities India Private Limited at ₹485 Cr (FY 2025). Earlier, Kavuru Vimal Kumar was a Director at Plerum Infra Projects Private Limited (2019–2024) and Additional Director at Dna Biotec Limited (2007–2009) and 11 more.

DIN 00502935
Primary Designation Director
Industry Chemicals
First Appointment 01 Oct 2007
Oldest Company Age 20 yrs
Largest company Cronus Pharma Specialities India Private Limited · ₹485 Cr (FY 2025)
Combined revenue ₹496 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jul 20182015₹485 Cr (FY 2025)Active
Anshra Realty Private Limited U68100TS2023PTC178646
Director01 Nov 20232023₹3.77 Cr (FY 2025)Active
Nortic Realty Private Limited U43900TS2023PTC178285
Director19 Oct 20232023₹3.74 Cr (FY 2025)Active
Blue Ivy Realty Private Limited U68100TS2023PTC178650
Director01 Nov 20232023₹2.84 Cr (FY 2025)Active
Director30 Sep 20242022₹51.8 Lakh (FY 2024)Active
Cronus Research Labs Private Limited U73100TG2014PTC096110
Director24 Oct 20142014₹74,430 (FY 2025)Active
Cronus Vetcare Private Limited U32509TS2026PTC209784
Director15 Jan 20262026Active
Rumson Realty Private Limited U68100TS2024PTC184138
Director04 Apr 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Mar 20192017₹214 Cr (FY 2024)Amalgamated
Dna Biotec Limited U24299TG2003PLC042283
Additional Director01 Oct 20072003Active
Celon Organics Private Limited U24239TG2005PTC046286
Director10 May 20082005Amalgamated
Celon Laboratories Private Limited U24232TG2001PTC036097
Director01 Dec 20072001₹148 Cr (FY 2025)Active
Director28 Sep 20182017₹20.4 Lakh (FY 2023)Amalgamated
Eugia Pharma Specialities Limited U24297TG2013PLC087048
Director17 Apr 20132013₹4,829 Cr (FY 2025)Active
Casper Pharma Private Limited U24233MH2016PTC423891
Director13 Jan 20162016₹30.43 Cr (FY 2024)Amalgamated
Designated Partner26 Jul 20162016Strike Off
Celon Life Sciences Limited U24239TG2006PLC049375
Director12 Nov 20072006Amalgamated
Citron Formulations Private Limited U24233TG2014PTC096904
Nominee Director19 Dec 20142014Strike Off
Director23 Feb 20102010₹2.6 Lakh (FY 2022)Strike Off
Director18 Jan 20082008Strike Off
Director18 Jan 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sage Developers Llp
Celon Life Sciences Limited
Cronus Pharma Specialities India Private Limited
Citron Formulations Private Limited
Premium access

Shareholding and investment profile for Kavuru Vimal Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavuru Vimal Kumar

Kavuru Vimal Kumar currently holds 9 directorships: Cronus Pharma Specialities India Private Limited (Director, since 16 Jul 2018, revenue ₹485 Cr (FY 2025)); Anshra Realty Private Limited (Director, since 01 Nov 2023, revenue ₹3.77 Cr (FY 2025)); Nortic Realty Private Limited (Director, since 19 Oct 2023, revenue ₹3.74 Cr (FY 2025)); Blue Ivy Realty Private Limited (Director, since 01 Nov 2023, revenue ₹2.84 Cr (FY 2025)); Pharsights Business Solutions Private Limited (Director, since 30 Sep 2024, revenue ₹51.8 Lakh (FY 2024)); and 4 more.

Kavuru Vimal Kumar was first appointed on 01 Oct 2007 as Additional Director at Dna Biotec Limited. The most recent appointment on record is 15 Jan 2026 at Cronus Vetcare Private Limited.

The 6 current companies of Kavuru Vimal Kumar that report revenue have a combined latest revenue of ₹496 Cr: Cronus Pharma Specialities India Private Limited ₹485 Cr (FY 2025); Anshra Realty Private Limited ₹3.77 Cr (FY 2025); Nortic Realty Private Limited ₹3.74 Cr (FY 2025); Blue Ivy Realty Private Limited ₹2.84 Cr (FY 2025); Pharsights Business Solutions Private Limited ₹51.8 Lakh (FY 2024); and 1 more.

Kavuru Vimal Kumar held 13 earlier board appointments: Plerum Infra Projects Private Limited (Director, 07 Mar 2019 to 15 Nov 2024); Dna Biotec Limited (Additional Director, 01 Oct 2007 to 01 Oct 2009); Celon Organics Private Limited (Director, 10 May 2008 to 31 Jul 2011); Celon Laboratories Private Limited (Director, 01 Dec 2007 to 13 Nov 2020); Mviyes Pharma Ventures Private Limited (Director, 28 Sep 2018 to 23 Oct 2020); and 8 more.

The current boards of Kavuru Vimal Kumar's companies include Mallemputi Ramakrishna Chowdary (Cronus Pharma Specialities India Private Limited), Srividya Elapakurti (Cronus Pharma Specialities India Private Limited), Raja Sekhar Kavuru (Anshra Realty Private Limited), Ritesh Ajitkumar Udhani (Pharsights Business Solutions Private Limited), Sithika Panigrahy (Pharsights Business Solutions Private Limited), Abbavaram Gopi Sudheer (Cronus Research Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available